CompoAtlas

Genestra Brands TM Phyto Greens

Natural health product licensed in Canada

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
pollen d'abeille

Source : Pollen

200 mgNot calculated
pollen d'abeille

Source : Apis mellifera

200 mgNot calculated
Bromélaïne de tige

Source : Ananas comosus - Tige

25 mgNot calculated
Bromélaïne de tige

Source : Ananas comosus - Tige

750,000 FCC PUNot calculated
Apium graveolens

Source : Graine(s)

25 mgNot calculated
Hordeum vulgare

Source : Feuille

400 mgNot calculated
Triticum aestivum

Source : Parties aériennes

400 mgNot calculated
Carica papaya

Source : Feuille

400 mgNot calculated
pectine

Source : Malus domestica - Fruit

25 mgNot calculated
Brassica oleracea var. italica

Source : Tête de fleur

600 mgNot calculated
Petroselinum crispum

Source : Petroselinum crispum -Leaf

25 mgNot calculated
bêta-carotène

Source : bêta-carotène

3.75 mgNot calculated
Malpighia glabra

Source : Fruit

Extraction ratio : 4:1

Dry plant equivalent : 100 mg

25 mgNot calculated
Nasturtium officinale

Source : Feuille

25 mgNot calculated
Vaccinium myrtillus

Source : Fruit

Extraction ratio : 4:1

Dry plant equivalent : 160 mg

40 mgNot calculated
Ginkgo biloba

Source : Feuille

Potency : 24 % Flavone glycosides

40 mgNot calculated
Fructooligosaccharides

Source : Fructooligosaccharides

Potency : 95 % fructans

1,000 mgNot calculated
papaïne

Source : Carica papaya, fruit

25 mgNot calculated
papaïne

Source : Carica papaya, fruit

50,000 FCC PUNot calculated
Brassica oleracea var. botrytis

Source : Tête de fleur

600 mgNot calculated

Non-medicinal ingredients

Not provided.

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Mesures1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Digestive enzyme. A source of antioxidants and vitamin A for the maintenance of good health; helps maintain eyesight, skin, membranes and immune function and helps in the development and maintenance of bones and teeth.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
Seroyal International
NPN or DIN-HM
80037585
Status
Inactive licence
Licence date
19 November 2012
Revision date
8 October 2014
Form
Poudre
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80037585

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vaccinium myrtillus
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

  • Ginkgo biloba
    Read the warning, when it applies and the studies cited

    GINKGO - GINKGO BILOBA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).

    Sources cited by Health Canada (3)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
    • WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
    • OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Contraindications

    Do not use if you are having a surgery (Gardner and McGuffin 2013).

    Sources cited by Health Canada (1)
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).

    Sources cited by Health Canada (3)
    • Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Health Canada monograph dated 25 July 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Photograph the packaging

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Genestra Brands TM Phyto Greens”, https://compoatlas.com/en/supplements/canada/80037585-genestra-brands-tm-phyto-greens, updated 8 October 2014.

List recorded in 2014. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line